| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSS1700039 | 注射用重组人特立帕肽 | teriparatide | Lyophilized | Biological Products(7) | New Drug Application | 2018-09-14 | 北京博康健基因科技有限公司,东莞太力生物工程有限公司,东莞宝丽健生物工程研究开发有限公司 | Certificate Issued | 2021-07-22 | view |